Sutro Biopharma, Inc. announced the expansion of its senior management team with the appointment of Edward C. Albini as chief financial officer. Mr. Albini has more than 25 years of life science industry experience, including more than 14 years in various financial management positions at Genentech.
Mr. Albini joins Sutro from Itero Biopharmaceuticals, where he was chief financial officer.